Accede al análisis completo con tu suscripción
Últimos 20 reportes · 10-K · 10-K/A · 10-Q · 8-K · Fuente: SEC EDGAR
Accede al análisis completo con tu suscripción
SEC CIK: 0001739104
Elanco Animal Health Incorporated and its subsidiaries (collectively, Elanco, the Company, we, us, or our) is a global leader in animal health, dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. We partner with farmers, pet owners, veterinarians and society to create value and help our customers improve the health of animals in their care, while also making a meaningful impact on the communities we serve. Our diverse, durable product portfolio is sold in more than 90 countries and serves animals across many species, primarily: dogs and cats (collectively, pet health) and cattle, poultry, swine and sheep (collectively, farm animal). Our purpose – making life better for animals makes life better – inspires us to Go Beyond for animals, our customers, our people and society. Go Beyond for Animals – Our strong portfolio, high-impact innovation, unique market approach and dedication to making life better allow us to go beyond for animals to address critical health needs and increase access to health products and services.
Ver másPrecio actual · USD
$24.11
Consenso de Analistas
Precio Objetivo — 12 meses
$26.00
Mínimo
+7.8%
$31.50
Mediana
+30.7%
$31.21
Promedio
+29.4%
$34.00
Máximo
+41.0%
P/E LTM
—
Precio / EPS LTM diluido
Gross Margin
55.4%
Gross profit / Ingresos
Operating Margin
3.5%
Op. income / Ingresos
R&D / Revenue
7.4%
R&D / Ingresos
Amort. Intang / Revenue
11.1%
Amort. intangibles / Ingresos
FCF Margin
7.5%
FCF / Ingresos
ROE (avg equity)
-3.0%
Benef. neto / Patrimonio
ROA (avg assets)
-1.5%
Benef. neto / Activo total
| Métrica | LTM jun 26 | 2025 | 2024 | 2023 | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INGRESOS Y MÁRGENES | |||||||||||
| Ingresos Totales | 5.020B | 4.715B | 4.439B | 4.417B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Cost of Revenue | 2.241B | 2.122B | 2.003B | 1.931B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Gross Profit | 2.779B | 2.593B | 2.436B | 2.486B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Gross Margin | 55.4% | 55.0% | 54.9% | 56.3% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| GASTOS OPERATIVOS | |||||||||||
| R&D (Research & Development) | 371.000M | 368.000M | 344.000M | 327.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| R&D / Revenue | 7.4% | 7.8% | 7.8% | 7.4% | 🔒 | 🔒 | |||||
| STOCK-BASED COMPENSATION | |||||||||||
| Stock-Based Compensation | 74.000M | 68.000M | 55.000M | 46.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| SBC / Revenue | 1.5% | 1.4% | 1.2% | 1.0% | 🔒 | 🔒 | |||||
| RESULTADO NETO | |||||||||||
| Pretax Income | -166.000M | -224.000M | 488.000M | -1.195B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Interest Expense (P&L) | — | — | — | 277.000M | 🔒 | 🔒 | |||||
| INVENTARIO Y LEASE | |||||||||||
| Inventario Neto | 1.769B | 1.737B | 1.574B | 1.735B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| LIQUIDEZ | |||||||||||
| Cash & Equivalentes | 530.000M | 545.000M | 468.000M | 352.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Total Liquid Assets | 530.000M | 545.000M | 468.000M | 352.000M | 🔒 | 🔒 | |||||
| BALANCE — ACTIVOS | |||||||||||
| PP&E Neto | 1.411B | 1.409B | 993.000M | 1.026B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Goodwill | 4.845B | 4.779B | 4.414B | 5.094B | 🔒 | 🔒 | |||||
| CAPITAL Y DEUDA | |||||||||||
| Deuda Total | 3.918B | 4.017B | 4.321B | 5.774B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Net Debt | 3.388B | 3.472B | 3.853B | 5.422B | 🔒 | 🔒 | |||||
| FLUJO DE CAJA Y CAPEX | |||||||||||
| Cash Flow Operativo (CFO) | 617.000M | 560.000M | 541.000M | 271.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Capex | 238.000M | 276.000M | 147.000M | 140.000M | 🔒 | 🔒 | |||||
| RATIOS | |||||||||||
| ROIC (NOPAT / IC) | — | — | 1.3% | — | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Gross Margin | 55.4% | 55.0% | 54.9% | 56.3% | 🔒 | 🔒 | |||||
Cifras en miles de millones (B) · Fuente: SEC/EDGAR
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| SG&A | 1.519B | 1.430B | 1.314B | 1.285B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Amortización Intangibles | 556.000M | 543.000M | 527.000M | 548.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Amort. Intang / Revenue | 11.1% | 11.5% | 11.9% | 12.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Income | 176.000M | 96.000M | 207.000M | -918.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Margin | 3.5% | 2.0% | 4.7% | -20.8% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Tax Expense | 33.000M | 8.000M | 150.000M | 36.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Beneficio Neto | -199.000M | -232.000M | 338.000M | -1.231B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Margen Neto | -4.0% | -4.9% | 7.6% | -27.9% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| EPS Diluido | -0.41 | -0.47 | 0.68 | -2.50 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| EPS Básico | -0.41 | -0.47 | 0.68 | -2.50 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Intangibles | 3.204B | 3.408B | 3.681B | 4.494B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Activo Total | 13.561B | 13.358B | 12.614B | 14.362B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Pasivo Total | 6.973B | 6.811B | 6.518B | 8.139B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Patrimonio Neto | 6.588B | 6.547B | 6.096B | 6.223B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Invested Capital | 10.506B | 10.491B | 11.207B | 12.561B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Acciones en Circulación | 499.622M | 496.975M | 494.446M | 492.845M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Free Cash Flow (FCF) | 379.000M | 284.000M | 394.000M | 131.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| FCF Margin | 7.5% | 6.0% | 8.9% | 3.0% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| NOPAT | — | — | 143.373M | — | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Adquisiciones (Business) | 76.000M | 0.00 | 41.000M | 19.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Operating Margin | 3.5% | 2.0% | 4.7% | -20.8% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| R&D / Revenue | 7.4% | 7.8% | 7.8% | 7.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Amort. Intang / Revenue | 11.1% | 11.5% | 11.9% | 12.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| FCF Margin | 7.5% | 6.0% | 8.9% | 3.0% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| ROE (avg equity) | -3.0% | -3.7% | 5.5% | -18.2% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| ROA (avg assets) | -1.5% | -1.8% | 2.5% | -8.3% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Margen Neto | -4.0% | -4.9% | 7.6% | -27.9% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Debt / Equity Ratio | 0.59x | 0.61x | 0.71x | 0.93x | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |